YARW
Yarrow Bioscience, Inc. - Common Stock (YARW)
$93
About Yarrow Bioscience, Inc. - Common Stock (YARW)
Yarrow Bioscience, Inc. is a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases. The company is developing YB-101, a potentially first-of-its-kind antibody therapy aimed at treating Graves disease (GD) and thyroid eye disease (TED). Yarrow Bioscience was founded in October 2025 and is headquartered in New Haven, CT.
Details
Daily high
$19.35
Daily low
$13.75
Price at open
$18.03
52 Week High
$44.28
52 Week Low
$9.65
Market cap
170.2M
Dividend yield
-
Volume
264,840
Avg. volume
190,419
P/E ratio
-1.17
Yarrow Bioscience, Inc. - Common Stock News
Details
Daily high
$19.35
Daily low
$13.75
Price at open
$18.03
52 Week High
$44.28
52 Week Low
$9.65
Market cap
170.2M
Dividend yield
-
Volume
264,840
Avg. volume
190,419
P/E ratio
-1.17